SRSF3 and colorectal carcinoma: Due to the prevalent high expression of SRSF3 in patients with metastatic lymph nodes (OR = 1.66; Supplementary Table 2) or distant metastases (OR = 1.61; Supplementary Table 2), we performed wound-healing assays and Transwell migration assays to investigate the effects of SRSF3 on the migration ability of CRC cells.